SFX by Ex Libris Inc.

Title:	Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies
Source:	Human Molecular Genetics [0964-6906] Bras, J yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Engelborghs, S. "DLB and PDD: a role for mutations in dementia and Parkinson disease genes?" Neurobiology of Aging 33.3 (2012): 62900000-4294967295.
description	2.	Kamp, F. "Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1." The EMBO Journal 29.20 (2010): 3571-3589.
description	3.	Duda, John E E. "Pathology and neurotransmitter abnormalities of dementia with Lewy bodies." Dementia and geriatric cognitive disorders 17.1 (2004): 3-14.
description	4.	Revesz, J. "Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study." Neuropathology and applied neurobiology 32.5 (2006): 492-504.
description	5.	Lippa, C F F. "DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers." Neurology 68.11 (2007): 812-9.
description	6.	McKeith, I G G. "Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium." Neurology 65.12 (2006): 1863-72.
description	7.	Mondon, K. "Visual recognition memory differentiates dementia with Lewy bodies and Parkinson's disease dementia." Journal of neurology, neurosurgery and psychiatry 78.7 (2007): 738-741.
description	8.	Bonifati, V. "Recent advances in the genetics of dementia with lewy bodies." Current Neurology and Neuroscience Reports 8.3 (2008): 187-9.
description	9.	Barton, B. "Clinical validation of movement disorder society-recommended diagnostic criteria for Parkinson's disease with dementia." Movement disorders 27.2 (2012): 248-253.
description	10.	Rosales Corral, Sergio A. "Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin." Journal of pineal research 52.2 (2011): 167-202.
description	11.	Set-Salvia, N. "Dementia Risk in Parkinson Disease: Disentangling the Role of MAPT Haplotypes." Archives of neurology 68.3 (2011): 359-364.
description	12.	Emre, M. "Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial." Lancet Neurology, The 9.10 (2010): 969-977.
description	13.	Todd, John M. "Pink1 suppresses α-synuclein-induced phenotypes in a Drosophila model of Parkinson’s disease." Genome 51.12 (2008): 1040-1046.
description	14.	Malavé, C. "Role of glypican-1 in the trophic activity on PC12 cells induced by cultured sciatic nerve conditioned medium: identification of a glypican-1-neuregulin complex." Brain Research (2003): 74-83.
description	15.	Hakomori, S. "Organization and function of glycosphingolipids in membrane." Proceedings of the Japan Academy. Series B, physical and biological sciences 81.6 (2005): 189-203.
description	16.	Chen, H. "Emerging functions of mammalian mitochondrial fusion and fission." Human molecular genetics 14.2 (2005): 283-9.
description	17.	Gross, R. "Cognitive impairment in Parkinson's disease and dementia with Lewy bodies: A spectrum of disease." Neuro-Signals 16.1 (2008): 24-34.
description	18.	Small, Gary W W. "Neuroimaging as a diagnostic tool in dementia with Lewy bodies." Dementia and geriatric cognitive disorders 17.0 suppl. (2004): 25-31.
description	19.	Varma, A. R. "Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia." Acta neurologica Scandinavica 105.4 (2002): 261-269.
description	20.	Ballard, C. G G. "Advances in the treatment of Alzheimer's disease: Benefits of dual cholinesterase inhibition." European neurology 47.1 (2002): 64-70.